Rubin Jiao

Prince Albert, SK S7N5E5, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Comparative In Vitro and In Vivo Evaluation of Anti-CCR8 Full-Sized IgG and Its Fab Fragments in Murine Colorectal Cancer Models.

Comparative In Vitro and In Vivo Evaluation of Anti-CCR8 Full-Sized IgG and Its Fab Fragments in Murine Colorectal Cancer Models.

Journal: Molecules (Basel, Switzerland)

Published: October 01, 2025

225Actinium-armed antibody targeting CCR8+ regulatory T cells synergizes with immunotherapy to promote tumor rejection in syngeneic colorectal cancer models.

225Actinium-armed antibody targeting CCR8+ regulatory T cells synergizes with immunotherapy to promote tumor rejection in syngeneic colorectal cancer models.

Journal: Frontiers in immunology

Published: July 08, 2025

Combination of Radioligand Therapy and Immunotherapy: How to Make It Work in Clinic?

Combination of Radioligand Therapy and Immunotherapy: How to Make It Work in Clinic?

Journal: ImmunoTargets and therapy

Published: February 10, 2025

Radioimmunotherapy as a pathogen-agnostic treatment method for opportunistic mucormycosis infections.

Radioimmunotherapy as a pathogen-agnostic treatment method for opportunistic mucormycosis infections.

Journal: Access microbiology

Published: July 10, 2023

A Theranostic Approach to Imaging and Treating Melanoma with 203Pb/212Pb-Labeled Antibody Targeting Melanin.

A Theranostic Approach to Imaging and Treating Melanoma with 203Pb/212Pb-Labeled Antibody Targeting Melanin.

Journal: Cancers

Published: May 18, 2023

In Vitro and In Vivo Characterization of 89Zirconium-Labeled Lintuzumab Molecule.

In Vitro and In Vivo Characterization of 89Zirconium-Labeled Lintuzumab Molecule.

Journal: Molecules (Basel, Switzerland)

Published: August 30, 2022

Targeting Melanin in Melanoma with Radionuclide Therapy.

Targeting Melanin in Melanoma with Radionuclide Therapy.

Journal: International journal of molecular sciences

Published: July 07, 2022

Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models.

Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 09, 2021

Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma.

Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma.

Journal: International journal of molecular sciences

Published: September 23, 2020

Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections.

Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections.

Journal: Molecules (Basel, Switzerland)

Published: July 03, 2020

Evaluating the Combination of Radioimmunotherapy and Immunotherapy in a Melanoma Mouse Model.

Evaluating the Combination of Radioimmunotherapy and Immunotherapy in a Melanoma Mouse Model.

Journal: International journal of molecular sciences

Published: December 31, 2019

Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium.

Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium.

Journal: Pharmaceutics

Published: June 22, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026